 | • レポートコード：D0GIR-00431 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、獣医腫瘍の世界市場を広く調査・分析し、今後の市場展望をまとめております。獣医腫瘍の種類別市場規模（外科、放射線、化学療法、免疫療法、その他（併用療法、標的療法））、用途別市場規模（犬、猫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：PetCure Oncology、Regeneus Ltd.、Boehringer Ingelheim、Accuray Incorporated、One Health、Varian Medical Systems、Morphogenesis, Inc.、Zoetis Karyopharm Therapeutics, Inc.、Elanco、Nippon Zenyaku Kogyo Co., Ltd.、Karyopharm Therapeutics, Inc. ・地域別グローバル市場分析 2015年-2020年 ・獣医腫瘍の北米市場（アメリカ、カナダ、メキシコ） ・獣医腫瘍のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・獣医腫瘍のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・獣医腫瘍の南米市場（ブラジル、アルゼンチン） ・獣医腫瘍の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科、放射線、化学療法、免疫療法、その他（併用療法、標的療法） ・用途別分析：犬、猫 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Veterinary Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Veterinary Oncology sales will be xx in 2020 from Veterinary Oncology million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Veterinary Oncology market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Veterinary Oncology industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Veterinary Oncology and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Veterinary Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Veterinary Oncology market has been segmented into:
Surgery
Radiology
Chemotherapy
Immunotherapy
Others (Combination Therapy, Targeted Therapy)
By Application, Veterinary Oncology has been segmented into:
Canine
Feline
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Veterinary Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Veterinary Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Veterinary Oncology market.
The report offers in-depth assessment of the growth and other aspects of the Veterinary Oncology market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Veterinary Oncology Market Share Analysis
Veterinary Oncology competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Veterinary Oncology sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Veterinary Oncology sales, revenue and market share for each player covered in this report.
The major players covered in Veterinary Oncology are:
PetCure Oncology
Regeneus Ltd.
Boehringer Ingelheim
Accuray Incorporated
One Health
Varian Medical Systems
Morphogenesis, Inc.
Zoetis Karyopharm Therapeutics, Inc.
Elanco
Nippon Zenyaku Kogyo Co., Ltd.
Karyopharm Therapeutics, Inc.
Among other players domestic and global, Veterinary Oncology market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Veterinary Oncology Market Overview
1.1 Product Overview and Scope of Veterinary Oncology
1.2 Classification of Veterinary Oncology by Type
1.2.1 Global Veterinary Oncology Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Veterinary Oncology Revenue Market Share by Type in 2019
1.2.3 Surgery
1.2.4 Radiology
1.2.5 Chemotherapy
1.2.6 Immunotherapy
1.2.7 Others (Combination Therapy, Targeted Therapy)
1.3 Global Veterinary Oncology Market by Application
1.3.1 Overview: Global Veterinary Oncology Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Canine
1.3.3 Feline
1.4 Global Veterinary Oncology Market by Regions
1.4.1 Global Veterinary Oncology Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Veterinary Oncology (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Veterinary Oncology Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Veterinary Oncology Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Veterinary Oncology Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Veterinary Oncology Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Veterinary Oncology Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Veterinary Oncology Industry Impact
1.5.1 COVID-19 Potential Implications for the Veterinary Oncology
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Veterinary Oncology
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 PetCure Oncology
2.1.1 PetCure Oncology Details
2.1.2 PetCure Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 PetCure Oncology SWOT Analysis
2.1.4 PetCure Oncology Product and Services
2.1.5 PetCure Oncology Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneus Ltd.
2.2.1 Regeneus Ltd. Details
2.2.2 Regeneus Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneus Ltd. SWOT Analysis
2.2.4 Regeneus Ltd. Product and Services
2.2.5 Regeneus Ltd. Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim SWOT Analysis
2.3.4 Boehringer Ingelheim Product and Services
2.3.5 Boehringer Ingelheim Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Accuray Incorporated
2.4.1 Accuray Incorporated Details
2.4.2 Accuray Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Accuray Incorporated SWOT Analysis
2.4.4 Accuray Incorporated Product and Services
2.4.5 Accuray Incorporated Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.5 One Health
2.5.1 One Health Details
2.5.2 One Health Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 One Health SWOT Analysis
2.5.4 One Health Product and Services
2.5.5 One Health Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Varian Medical Systems
2.6.1 Varian Medical Systems Details
2.6.2 Varian Medical Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Varian Medical Systems SWOT Analysis
2.6.4 Varian Medical Systems Product and Services
2.6.5 Varian Medical Systems Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Morphogenesis, Inc.
2.7.1 Morphogenesis, Inc. Details
2.7.2 Morphogenesis, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Morphogenesis, Inc. SWOT Analysis
2.7.4 Morphogenesis, Inc. Product and Services
2.7.5 Morphogenesis, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Zoetis Karyopharm Therapeutics, Inc.
2.8.1 Zoetis Karyopharm Therapeutics, Inc. Details
2.8.2 Zoetis Karyopharm Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Zoetis Karyopharm Therapeutics, Inc. SWOT Analysis
2.8.4 Zoetis Karyopharm Therapeutics, Inc. Product and Services
2.8.5 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Elanco
2.9.1 Elanco Details
2.9.2 Elanco Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Elanco SWOT Analysis
2.9.4 Elanco Product and Services
2.9.5 Elanco Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nippon Zenyaku Kogyo Co., Ltd.
2.10.1 Nippon Zenyaku Kogyo Co., Ltd. Details
2.10.2 Nippon Zenyaku Kogyo Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nippon Zenyaku Kogyo Co., Ltd. SWOT Analysis
2.10.4 Nippon Zenyaku Kogyo Co., Ltd. Product and Services
2.10.5 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.11 Karyopharm Therapeutics, Inc.
2.11.1 Karyopharm Therapeutics, Inc. Details
2.11.2 Karyopharm Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Karyopharm Therapeutics, Inc. SWOT Analysis
2.11.4 Karyopharm Therapeutics, Inc. Product and Services
2.11.5 Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Veterinary Oncology Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Veterinary Oncology Players Market Share
3.2.2 Top 10 Veterinary Oncology Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Veterinary Oncology Revenue and Market Share by Regions
4.2 North America Veterinary Oncology Revenue and Growth Rate (2015-2020)
4.3 Europe Veterinary Oncology Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Veterinary Oncology Revenue and Growth Rate (2015-2020)
4.5 South America Veterinary Oncology Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Veterinary Oncology Revenue and Growth Rate (2015-2020)
5 North America Veterinary Oncology Revenue by Countries
5.1 North America Veterinary Oncology Revenue by Countries (2015-2020)
5.2 USA Veterinary Oncology Revenue and Growth Rate (2015-2020)
5.3 Canada Veterinary Oncology Revenue and Growth Rate (2015-2020)
5.4 Mexico Veterinary Oncology Revenue and Growth Rate (2015-2020)
6 Europe Veterinary Oncology Revenue by Countries
6.1 Europe Veterinary Oncology Revenue by Countries (2015-2020)
6.2 Germany Veterinary Oncology Revenue and Growth Rate (2015-2020)
6.3 UK Veterinary Oncology Revenue and Growth Rate (2015-2020)
6.4 France Veterinary Oncology Revenue and Growth Rate (2015-2020)
6.5 Russia Veterinary Oncology Revenue and Growth Rate (2015-2020)
6.6 Italy Veterinary Oncology Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Veterinary Oncology Revenue by Countries
7.1 Asia-Pacific Veterinary Oncology Revenue by Countries (2015-2020)
7.2 China Veterinary Oncology Revenue and Growth Rate (2015-2020)
7.3 Japan Veterinary Oncology Revenue and Growth Rate (2015-2020)
7.4 Korea Veterinary Oncology Revenue and Growth Rate (2015-2020)
7.5 India Veterinary Oncology Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Veterinary Oncology Revenue and Growth Rate (2015-2020)
8 South America Veterinary Oncology Revenue by Countries
8.1 South America Veterinary Oncology Revenue by Countries (2015-2020)
8.2 Brazil Veterinary Oncology Revenue and Growth Rate (2015-2020)
8.3 Argentina Veterinary Oncology Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Veterinary Oncology by Countries
9.1 Middle East & Africa Veterinary Oncology Revenue by Countries (2015-2020)
9.2 Saudi Arabia Veterinary Oncology Revenue and Growth Rate (2015-2020)
9.3 UAE Veterinary Oncology Revenue and Growth Rate (2015-2020)
9.4 Egypt Veterinary Oncology Revenue and Growth Rate (2015-2020)
9.5 South Africa Veterinary Oncology Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Veterinary Oncology Revenue and Market Share by Type (2015-2020)
10.2 Global Veterinary Oncology Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2015-2025)
10.4 Radiology Revenue Growth Rate (2015-2025)
10.5 Chemotherapy Revenue Growth Rate (2015-2025)
10.6 Immunotherapy Revenue Growth Rate (2015-2025)
10.7 Others (Combination Therapy, Targeted Therapy) Revenue Growth Rate (2015-2025)
11 Global Veterinary Oncology Market Segment by Application
11.1 Global Veterinary Oncology Revenue Market Share by Application (2015-2020)
11.2 Veterinary Oncology Market Forecast by Application (2019-2024)
11.3 Canine Revenue Growth (2015-2020)
11.4 Feline Revenue Growth (2015-2020)
12 Global Veterinary Oncology Market Size Forecast (2021-2025)
12.1 Global Veterinary Oncology Market Size Forecast (2021-2025)
12.2 Global Veterinary Oncology Market Forecast by Regions (2021-2025)
12.3 North America Veterinary Oncology Revenue Market Forecast (2021-2025)
12.4 Europe Veterinary Oncology Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Veterinary Oncology Revenue Market Forecast (2021-2025)
12.6 South America Veterinary Oncology Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Veterinary Oncology Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Veterinary Oncology Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Veterinary Oncology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Veterinary Oncology Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Veterinary Oncology Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Veterinary Oncology Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. PetCure Oncology Corporate Information, Location and Competitors
Table 7. PetCure Oncology Veterinary Oncology Major Business
Table 8. PetCure Oncology Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 9. PetCure Oncology SWOT Analysis
Table 10. PetCure Oncology Veterinary Oncology Product and Solutions
Table 11. PetCure Oncology Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Regeneus Ltd. Corporate Information, Location and Competitors
Table 13. Regeneus Ltd. Veterinary Oncology Major Business
Table 14. Regeneus Ltd. Veterinary Oncology Total Revenue (USD Million) (2018-2019)
Table 15. Regeneus Ltd. SWOT Analysis
Table 16. Regeneus Ltd. Veterinary Oncology Product and Solutions
Table 17. Regeneus Ltd. Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 19. Boehringer Ingelheim Veterinary Oncology Major Business
Table 20. Boehringer Ingelheim Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 21. Boehringer Ingelheim SWOT Analysis
Table 22. Boehringer Ingelheim Veterinary Oncology Product and Solutions
Table 23. Boehringer Ingelheim Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Accuray Incorporated Corporate Information, Location and Competitors
Table 25. Accuray Incorporated Veterinary Oncology Major Business
Table 26. Accuray Incorporated Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 27. Accuray Incorporated SWOT Analysis
Table 28. Accuray Incorporated Veterinary Oncology Product and Solutions
Table 29. Accuray Incorporated Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. One Health Corporate Information, Location and Competitors
Table 31. One Health Veterinary Oncology Major Business
Table 32. One Health Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 33. One Health SWOT Analysis
Table 34. One Health Veterinary Oncology Product and Solutions
Table 35. One Health Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Varian Medical Systems Corporate Information, Location and Competitors
Table 37. Varian Medical Systems Veterinary Oncology Major Business
Table 38. Varian Medical Systems Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 39. Varian Medical Systems SWOT Analysis
Table 40. Varian Medical Systems Veterinary Oncology Product and Solutions
Table 41. Varian Medical Systems Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Morphogenesis, Inc. Corporate Information, Location and Competitors
Table 43. Morphogenesis, Inc. Veterinary Oncology Major Business
Table 44. Morphogenesis, Inc. Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 45. Morphogenesis, Inc. SWOT Analysis
Table 46. Morphogenesis, Inc. Veterinary Oncology Product and Solutions
Table 47. Morphogenesis, Inc. Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Zoetis Karyopharm Therapeutics, Inc. Corporate Information, Location and Competitors
Table 49. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Major Business
Table 50. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 51. Zoetis Karyopharm Therapeutics, Inc. SWOT Analysis
Table 52. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Product and Solutions
Table 53. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Elanco Corporate Information, Location and Competitors
Table 55. Elanco Veterinary Oncology Major Business
Table 56. Elanco Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 57. Elanco SWOT Analysis
Table 58. Elanco Veterinary Oncology Product and Solutions
Table 59. Elanco Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Nippon Zenyaku Kogyo Co., Ltd. Corporate Information, Location and Competitors
Table 61. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Major Business
Table 62. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 63. Nippon Zenyaku Kogyo Co., Ltd. SWOT Analysis
Table 64. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Product and Solutions
Table 65. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Karyopharm Therapeutics, Inc. Corporate Information, Location and Competitors
Table 67. Karyopharm Therapeutics, Inc. Veterinary Oncology Major Business
Table 68. Karyopharm Therapeutics, Inc. Veterinary Oncology Total Revenue (USD Million) (2017-2018)
Table 69. Karyopharm Therapeutics, Inc. SWOT Analysis
Table 70. Karyopharm Therapeutics, Inc. Veterinary Oncology Product and Solutions
Table 71. Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global Veterinary Oncology Revenue (Million USD) by Players (2015-2020)
Table 73. Global Veterinary Oncology Revenue Share by Players (2015-2020)
Table 74. Global Veterinary Oncology Revenue (Million USD) by Regions (2015-2020)
Table 75. Global Veterinary Oncology Revenue Market Share by Regions (2015-2020)
Table 76. North America Veterinary Oncology Revenue by Countries (2015-2020)
Table 77. North America Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Table 78. Europe Veterinary Oncology Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific Veterinary Oncology Revenue (Million USD) by Countries (2015-2020)
Table 80. South America Veterinary Oncology Revenue by Countries (2015-2020)
Table 81. South America Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa Veterinary Oncology Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Table 84. Global Veterinary Oncology Revenue (Million USD) by Type (2015-2020)
Table 85. Global Veterinary Oncology Revenue Share by Type (2015-2020)
Table 86. Global Veterinary Oncology Revenue Forecast by Type (2021-2025)
Table 87. Global Veterinary Oncology Revenue by Application (2015-2020)
Table 88. Global Veterinary Oncology Revenue Share by Application (2015-2020)
Table 89. Global Veterinary Oncology Revenue Forecast by Application (2021-2025)
Table 90. Global Veterinary Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Veterinary Oncology Picture
Figure 2. Global Veterinary Oncology Revenue Market Share by Type in 2019
Figure 3. Surgery Picture
Figure 4. Radiology Picture
Figure 5. Chemotherapy Picture
Figure 6. Immunotherapy Picture
Figure 7. Others (Combination Therapy, Targeted Therapy) Picture
Figure 8. Veterinary Oncology Revenue Market Share by Application in 2019
Figure 9. Canine Picture
Figure 10. Feline Picture
Figure 11. Global Veterinary Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Veterinary Oncology Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Veterinary Oncology Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Veterinary Oncology Revenue Market Share in 2019
Figure 20. Global Top 10 Players Veterinary Oncology Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Veterinary Oncology Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Veterinary Oncology Revenue Market Share by Regions (2015-2020)
Figure 24. Global Veterinary Oncology Revenue Market Share by Regions in 2018
Figure 25. North America Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 26. Europe Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 28. South America Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 30. North America Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Figure 31. North America Veterinary Oncology Revenue Market Share by Countries in 2019
Figure 32. USA Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 33. Canada Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 35. Europe Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Veterinary Oncology Revenue Market Share by Countries in 2019
Figure 37. Germany Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 38. UK Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 39. France Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 40. Russia Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 41. Italy Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Veterinary Oncology Revenue Market Share by Countries in 2019
Figure 44. China Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 45. Japan Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 46. Korea Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 47. India Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 49. South America Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Figure 50. South America Veterinary Oncology Revenue Market Share by Countries in 2019
Figure 51. Brazil Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Veterinary Oncology Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Veterinary Oncology Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 56. UAE Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Veterinary Oncology Revenue and Growth Rate (2015-2020)
Figure 59. Global Veterinary Oncology Revenue Share by Type (2015-2020)
Figure 60. Global Veterinary Oncology Revenue Share by Type in 2019
Figure 61. Global Veterinary Oncology Market Share Forecast by Type (2021-2025)
Figure 62. Global Surgery Revenue Growth Rate (2015-2020)
Figure 63. Global Radiology Revenue Growth Rate (2015-2020)
Figure 64. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 65. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 66. Global Others (Combination Therapy, Targeted Therapy) Revenue Growth Rate (2015-2020)
Figure 67. Global Veterinary Oncology Revenue Share by Application (2015-2020)
Figure 68. Global Veterinary Oncology Revenue Share by Application in 2019
Figure 69. Global Veterinary Oncology Market Share Forecast by Application (2021-2025)
Figure 70. Global Canine Revenue Growth Rate (2015-2020)
Figure 71. Global Feline Revenue Growth Rate (2015-2020)
Figure 72. Global Veterinary Oncology Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Veterinary Oncology Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Veterinary Oncology Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Veterinary Oncology Revenue Market Forecast (2021-2025)
Figure 76. Europe Veterinary Oncology Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Veterinary Oncology Revenue Market Forecast (2021-2025)
Figure 78. South America Veterinary Oncology Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Veterinary Oncology Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
獣医画像の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Veterinary Imaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 2503.2 million by 2025, from USD 2152 million in 2019. The Veterinary Imaging …- 獣医用インキュベーターの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Veterinary Incubators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Veterinary Incubators m…
- 獣医用遠隔放射線診断の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Veterinary Teleradiology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Veterinary Teleradio…
- 獣医用超音波検査装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Veterinary Ultrosound Machine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 腫瘍学治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drugs for Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…